# OnCo record bavarian-nordic (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bavarian-nordic/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bavarian-nordic" ;
  schema:name "Bavarian Nordic"@en ;
  schema:alternateName "Bavarian Nordic A/S"@en ;
  schema:description "Bavarian Nordic is a Danish vaccine company whose poxvirus-based prostate cancer vaccine PROSTVAC failed the phase 3 PROSPECT trial in 2017, after which it concentrated on infectious disease vaccines such as its smallpox and mpox vaccine."@en ;
  schema:url <https://onco.cc/companies/bavarian-nordic/>, <https://www.bavarian-nordic.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bavarian_Nordic> ;
  owl:sameAs <http://www.wikidata.org/entity/Q812002> ;
  schema:citation <https://www.bavarian-nordic.com>, <https://clinicaltrials.gov/search?lead=Bavarian%20Nordic>, <https://en.wikipedia.org/wiki/Bavarian_Nordic> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "DK" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .